July 1st! Negotiation results of landing drug prices in 18 provinces (with details of medical insurance linkage)

Source: e-medicated Facebook, July 30, 2016, is the last day of drug price negotiation at all places specified in the notice of national health and Family Planning Commission on centralized purchase of negotiated drugs Through combing the official websites of the health and family planning commissions of all 31 provinces, cities and autonomous regions, the final statistical data of e-drug managers show that: in the 40 days from May 20 to July 1, after the health and Family Planning Commission issued the notice on doing a good job of national negotiation on centralized drug procurement, there were 12 Provinces and autonomous regions have released the corresponding documents on the implementation of national drug price negotiations on the official website of the provincial health and Family Planning Commission Among the 12 provinces' landing list, it is of great concern that Beijing, Shanghai, Tianjin and Chongqing have not issued corresponding landing documents; according to relevant sources, there are still a number of provinces that will issue landing plans before the middle of July, and the reason why they fail to report in time also reflects how to specifically solve the key problems involved in the national drug price negotiation In addition, before the national drug price negotiation, in fact, the three drugs involved in price reduction, as mature products in the market, have been included in various insurance catalogs For example, before May 20, ektini and gefitini had entered into urban workers' and residents' insurance, new rural cooperative insurance or serious illness insurance in eight provinces and autonomous regions through separate negotiations The eight provinces and autonomous regions include Zhejiang, Hunan, Inner Mongolia, Gansu, Qinghai, Ningxia, Tibet and Xinjiang, among which Hunan and Inner Mongolia issued corresponding implementation documents after May 20 That is to say, as of June 30, a total of 18 provinces and autonomous regions have taken corresponding purchase and reimbursement measures for three drugs in the national drug price negotiation, while the rest of the relevant landing documents of provinces, cities and autonomous regions have not yet been issued Almost all provinces have issued corresponding documents, which take the connection with medical insurance as an important landing measure for all regions, and made key statements In addition to the list of reimbursement for urban employees, urban residents and NCMS from several provinces before drug price negotiation, most provinces after drug price negotiation are within the scope of compliance reimbursement for NCMS and serious illness insurance The only difference is Shaanxi Province On June 28, the health and Family Planning Commission of Shaanxi Province issued the notice on doing a good job in national negotiation of drug procurement, which said: "according to the national requirements and overall consideration of the medical insurance financing level of our province, the three national negotiation drugs published will be temporarily included in the reimbursement scope of serious illness insurance for urban and rural residents of our province, and relevant reimbursement policies will be well connected in each overall planning area." What should be pointed out here is that Shaanxi Province is the only one dominated by the health and Family Planning Commission in the process of "two guarantees in one" policy Table 1: medical insurance convergence of national drug price negotiation in different regions from May 20 to June 30 Table 2: medical insurance convergence of three price reduced products before national drug price negotiation